KESTRA MEDICAL TECHNOLOGIES, LTD.
KESTRA MEDICAL TECHNOLOGIES, LTD.
Your view on KMTS
Overview
What the company does, where it operates, and who runs it.
About KESTRA MEDICAL TECHNOLOGIES, LTD.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Brian Webster
- Headquarters
- US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Brian Webster
- Headquarters
- US
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA).
The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for KESTRA MEDICAL TECHNOLOGIES, LTD., and the rating behind it. KMTS last traded at $22.85; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for KESTRA MEDICAL TECHNOLOGIES, LTD.. Starting points for KESTRA MEDICAL TECHNOLOGIES, LTD.: EPS -$2.25, beta 0.62 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for KESTRA MEDICAL TECHNOLOGIES, LTD.. KESTRA MEDICAL TECHNOLOGIES, LTD. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for KESTRA MEDICAL TECHNOLOGIES, LTD.. Trailing twelve-month EPS for KESTRA MEDICAL TECHNOLOGIES, LTD. stands at -$2.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for KESTRA MEDICAL TECHNOLOGIES, LTD.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
KESTRA MEDICAL TECHNOLOGIES, LTD. valued side by side against its closest peers. KESTRA MEDICAL TECHNOLOGIES, LTD. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold KESTRA MEDICAL TECHNOLOGIES, LTD., and how their positions are changing. At a $1.34B market value, institutional positions materially move KESTRA MEDICAL TECHNOLOGIES, LTD.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by KESTRA MEDICAL TECHNOLOGIES, LTD. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming KESTRA MEDICAL TECHNOLOGIES, LTD.. KESTRA MEDICAL TECHNOLOGIES, LTD. is a $1.34B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming KESTRA MEDICAL TECHNOLOGIES, LTD.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for KESTRA MEDICAL TECHNOLOGIES, LTD.. Coverage tracks KESTRA MEDICAL TECHNOLOGIES, LTD. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.